Novel concentration-killing curve method for estimation of bactericidal potency of antibiotics in an in vitro dynamic model

Antimicrobial Agents and Chemotherapy

Volumn 48, Issue 10, 2004, Pages 3884-3891

  Liu, Y Q ^a,b   Zhang, Y Z ^a   Gao, P J ^a  

^a SHANDONG UNIVERSITY   (China)

^b SHANDONG PEANUT RESEARCH INSTITUTE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AGAR; ANTIBIOTIC AGENT; ENOXACIN; GENTAMICIN; PENICILLIN G;

ARTICLE; BACTERIAL CELL; BACTERIAL STRAIN; BACTERIAL SURVIVAL; BACTERICIDAL ACTIVITY; BACTERIUM COLONY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG POTENCY; ESCHERICHIA COLI; INCUBATION TIME; INOCULATION; NONHUMAN; PRIORITY JOURNAL; REPRODUCIBILITY;

ALGORITHMS; ANTI-BACTERIAL AGENTS; COLONY COUNT, MICROBIAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ENOXACIN; ESCHERICHIA COLI; GENTAMICINS; LOGISTIC MODELS; MICROBIAL SENSITIVITY TESTS; PENICILLINS;

EID: 4644288902     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.48.10.3884-3891.2004     Document Type: Article

References (39)

1. Aviles, P., C. Falcoz, M. J. Guillén, R. San Roman, F. Gómez De Las Heras, and D. Gargallo-Viola. 2001. Correlation between In vitro and in vivo activities of GM 237354, a new sordarin derivative, against Candida albicans in an in vitro pharmacokinetic-pharmacodynamic model and influence of protein binding. Antimicrob. Agents Chemother. 45:2746-2754.
2. Branson, E. 2001. Clinical relevance of minimum inhibitory concentrations. Aquaculture 196:289-296.
3. Christfilogiannis, P. 2001. Current inoculation methods in MIC determination. Aquaculture 196:297-302.
4. Drlica, K. 2003. The mutant selection window and antimicrobial resistance. J. Antimicrob. Chemother. 52:11-17.
5. Dubin, D. T., J. E. Fitzgibbon, M. D. Nahri, and J. F. John. 1999. Topo-isomerase sequences of coagulase-negative staphylococcal isolates resistant to ciprofloxacin or trovafloxacin. Antimicrob. Agents Chemother. 43:1631-1637.
6. Ernst, J. E., E. E. Roling, C. R. Petzold, D. J. Keele, and M. E. Klepser. 2002. In vitro activity of micafungin (FK-463) against Candida spp.: microdilution, time-kill, and postantifungal-effect studies. Antimicrob. Agents Chemother. 46:3846-3853.
7. Feldman, H. A. 1972. Mathematical theory of complex ligand-binding system of equilibrium. Anal. Biochem. 48:317-338.
8. Firsov, A. A., M. Ruble, D. Gilbert, D. Savarino, B. Manzano, A. A. Medeiros, and S. H. Zinner. 1997. Net effect of inoculum size on antimicrobial action of ampicillin-sulbactam: studies using an in vitro dynamic model. Antimicrob. Agents Chemother. 41:7-12.
9. Firsov, A. A., S. N. Vostrov, A. A. Shevchenko, and G. Cornagla. 1997. Parameters of bacterial killing and regrowth kinetics and antimicrobial effect examined in terms of area under the concentration-time curve relationships: action of ciprofloxacin against Escherichia coli in an in vitro dynamic model. Antimicrob. Agents Chemother. 41:1281-1287.
10. Firsov, A. A., S. N. Vostroy, O. Kononenko, S. H. Zinner, and Y. A. Portnoy. 1999. Prediction of the effects of inoculum size on the antimicrobial action of trovafloxacin and ciprofloxacin against Staphylococcus aureus and Escherichia coli in an in vitro dynamic model. Antimicrob. Agents Chemother. 43:498-502.
11. Firsov, A. A., S. N. Vostrov, I. Y. Lubenko, K. Drlica, Y. A. Portnoy, and S. H. Zinner. 2003. In vitro pharmacodynamic evaluation of the mutant selection window hypothesis using four fluoroquinolones against Staphylococcus aureus. Antimicrob. Agents Chemother. 47:1604-1613.
12. Franklin, R. C. 1999. Genetic methods for assessing antimicrobial resistance. Antimicrob. Agents Chemother. 43:199-212.
13. Gamow, G. 2002. One, two, three ... infinity: facts and speculations of science. Recension translated by Y. N. Bao. Science Press, Beijing, China.
14. Gunnar, K., D. F. J. Brown, F. W. Goldstein, A. P. MacGowan, J. W. Mouton, A. Österlund, A. Rodloff, M. Steinbakk, P Urbaskova, and A. Vatopoulos. 2003. European harmonization of MIC breakpoints for antimicrobial susceptibility testing of bacteria. J. Antimicrob. Chemother. 52:145-148.
15. Hyatt, J. M., D. E. Nix, and J. J. Schentag. 1994. Pharmacokinetics and pharmacodynamic activities of ciprofloxacin against strains of Streptococcus pneumoniae, Staphylococcus aureus, and Pseudomonas aeruginosa for which MICs are similar. Antimicrob. Agents Chemother. 38:2730-2737.
16. Jacqueline, C., B. Eric, P. Lucia, B. David, H. Antoine, C. Jocelyne, K. Marie-France, P. Gilles, and D. Bugnon. 2002. In vivo efficacy of continuous infusion versus intermittent dosing of linezolid compared to vancomycin in a methicillin-resistant Staphylococcus aureus rabbit endocarditis model. Antimicrob. Agents Chemother. 46:3706-3711.
17. Jensen, A. L. 1975. Comparison of logistic equation for population growth. Biometric 31:853-862.
18. Junichi, M., Y. Hisashi, M. Junko, F. Yoshiko, K. Sumiko, M. Shinzaburo, T. Yozo, W. Yasuo, and N. Hirokazu. 1997. Characteristics of quinolone-induced small colony variants in Staphylococcus aureus. J. Antimicrob. Chemother. 39:697-705.
19. Lass-Flörl, C., C. Speth, G. Kofler, M. P. Dierch, E. Gunsilius, and R. Würzner. 2003. Effect of increasing inoculum sizes of Aspergillus hyphae on MICs and MFCs of antifungal agents by broth microdilution method. Int. J. Antimicrob. Agents 21:229-233.
20. Lin, S., I. Y. Hsiao, and S. M. Hsu. 1997. Determination of the dissociation constant of phosvitin-anti-phosphoserine interaction by affinity capillary electrophoresis. Anal. Biochem. 254:9-17.
21. Liu, Y. Q., Y. Z. Zhang, S. G. Liu, J. L. Jin, and P. J. Gao. 2003. Comparative inhibitory effects of sanhuang, berberine and gentamicin against E. coli. Chin. J. Environ. Biol. 9:302-306.
22. Martineau, F., F. J. Picard, N. Lansac, C. Ménard, P. H. Roy, M. Ouellette, and M. G. Bergeron. 2000. Correlation between the resistance genotype determined by multiplex PCR assays and the antibiotic susceptibility patterns of Staphylococcus aureus and Staphylococcus epidermidis. Antimicrob. Agents Chemother. 44:231-238.
23. McDermott, P. F., R. D. Walker, and D. G. White. 2003. Antimicrobials: modes of action and mechanisms of resistance. Int. J. Toxicol. 22:135-143.
24. Morton, N. S. 2000. Impact of antimicrobial agents and chemotherapy from 1972 to 1998. Antimicrob. Agents Chemother. 44:2009-2016.
25. Motulsky, H. J., and A. Christopoulos. 2003. Fitting models to biological data using linear and nonlinear regression. A practical guide to curve fitting. Graph Pad Software Inc., San Diego, Calif.
26. Mouton, J. W., and J. G. D. Hollander. 1994. Killing of Pseudomonas aeruginosa during continuous and intermittent infusion of ceftazidime in an in vitro pharmacokinetic model. Antimicrob. Agents Chemother. 38:931-936.
27. Mouton, J. W., A. A. T. M. M. Vinks, and N. C. Punt. 1997. Pharmacokinetic-pharmacodynamic modeling of activity of ceftazidime during continuous and intermittent infusion. Antimicrob. Agents Chemother. 41:733-738.
28. Mouton, J. W. 2002. Breakpoints: current practice and future perspectives. Int. J. Antimicrob. Agents 19:323-331.
29. Mouton, J. W., M. N. Dudley, O. Cars, H. Derendorf, and G. L. Drusano. 2002. Standardization of pharmacodynamics (PK/PD) terminology for anti-infective drugs. Int. J. Antimicrob. Agents 19:355-358.
30. National Committee for Clinical Laboratory Standards. 2002. Performance standards for antimicrobial disk and dilution susceptibility tests for bacteria isolated from animals: approved standard, 2nd ed. NCCLS document M31-A2. National Committee for Clinical Laboratory Standards, Wayne, Pa.
31. Pfaller, M. A., R. N. Jones, and D. H. Walter. 2001. Proposed quality control guidelines for National Committee for Clinical Laboratory Standards susceptibility tests using the veterinary antimicrobial agent tiamulin. Diagn. Microbiol. Infect. Dis. 40:67-70.
32. Poole, K. 2002. Mechanisms of bacterial biocide and antibiotic resistance. Appl. Microbiol. 31:55S-64S.
33. Rang, H. P., M. M. Dale, and J. M. Ritter. 1999. Pharmacology, 4th ed. Churchill Livingstone, Edinburgh, Scotland.
34. max in ligand binding experiments. I. Homologous and heterologous binding to one or two classes of sites. Anal. Biochem. 174:636-649.
35. Smith, P., M. P. Hiney, and O. B. Samuelsen. 1994. Bacterial resistance to antimicrobial agents in fish farming: a critical evaluation of method and meaning. Annu. Rev. Fish Dis. 4:273-313.
36. Sniegowski, P. D. 1995. A test of the directed mutation hypothesis in Escherichia coli MCS2 using replica plating. J. Bacteriol. 177:1119-1120.
37. Spangler, S. K., M. R. Jacobs, and P. C. Appelbaum. 1997. MIC and time-kill studies of antipneumococcal activity of GV 118819X (sanfetrinem) compared with those of other agents. Antimicrob. Agents Chemother. 41:148-155.
38. Stanier, R. Y., J. L. Ingraham, M. L. Wheelis, and P. R. Painter. 1986. The microbial world, 5th ed., p. 238. Prentice-Hall, Englewood Cliffs, N.J.
39. Wheat, P. F. 2001. History and development of antimicrobial susceptibility testing methodology. J. Antimicrob. Chemother. 48:1-4.